Impact of Blood Lead and Manganese on MASLD Prevalence

Introduction to Metabolic Dysfunction-Associated Steatotic Liver Disease

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a term that has recently gained traction in the medical community as a way to encapsulate a broader range of liver conditions linked to metabolic dysfunction. Previously known as Non-Alcoholic Fatty Liver Disease (NAFLD), MASLD aims to reduce stigma and improve understanding among patients regarding their liver health. The condition is characterized by the accumulation of fat in liver cells, primarily driven by metabolic risk factors such as obesity, type 2 diabetes, and dyslipidemia. This paradigm shift in nomenclature is crucial in emphasizing the underlying metabolic dysfunction rather than merely focusing on the presence of fatty liver.

The prevalence of MASLD has been rising globally, necessitating a closer examination of its etiology and contributing factors. Recent studies have suggested a potential link between environmental toxins, specifically heavy metals like lead and manganese, and the development of MASLD. These metals have been shown to disrupt metabolic processes, leading to increased liver fat accumulation and, eventually, liver disease. Understanding the relationship between these metals and MASLD not only enhances our grasp of this liver condition but also shines a light on public health concerns related to environmental exposure.

Influence of Blood Lead and Manganese on Liver Health

Lead and manganese are metals widely distributed in the environment, arising from both natural and anthropogenic sources. Lead exposure is particularly concerning due to its long-term effects on human health, including its role as an endocrine disruptor. Chronic exposure to lead has been linked to metabolic disorders, including diabetes and effects on lipid metabolism, which may contribute to the onset of MASLD (Guo et al., 2025).

Manganese, while essential for various physiological processes, can become toxic at elevated exposure levels. It is known to play a role in the regulation of several metabolic pathways, particularly those involved in lipid metabolism and oxidative stress response. Studies suggest that increased blood levels of manganese are associated with metabolic syndrome, which is a known risk factor for MASLD (Guo et al., 2025).

The interaction of these metals with liver health is multifaceted. For instance, lead exposure has been shown to induce oxidative stress and inflammation in liver cells, leading to dysregulation of lipid metabolism and subsequent steatosis. Similarly, manganese’s effects on mitochondrial function and cellular metabolism can exacerbate fat accumulation in the liver, further contributing to the progression of MASLD (Guo et al., 2025).

Methodology for Assessing the Relationship with MASLD

This study utilized data from the National Health and Nutrition Examination Survey (NHANES) collected from 2017 to 2020. A cross-sectional analysis was performed, including 4,475 participants who met the eligibility criteria. The primary focus was to assess the relationship between blood lead and manganese levels and the prevalence of MASLD, as determined by Controlled Attenuation Parameter (CAP) scores from non-invasive liver elastography measurements.

The statistical analysis involved multivariable linear regression and multiple logistic regression models. These models were adjusted for various potential confounders, including age, sex, ethnicity, and other metabolic risk factors, to ensure robust and reliable results. This comprehensive approach allowed for a nuanced understanding of how blood lead and manganese levels correlate with the presence of MASLD.

Table 1: Participant Demographics

Analysis of Results: Correlation with CAP and MASLD

The results of the study indicated a significant positive correlation between elevated levels of blood lead and manganese and CAP scores, which reflect the degree of liver steatosis. Specifically, participants with higher blood lead levels showed a 25% increased likelihood of being diagnosed with MASLD compared to those with lower levels. Similarly, an increase in blood manganese levels was linked to a 30% higher risk of MASLD diagnosis.

Table 2: Correlation of Blood Metals with CAP Scores

These findings suggest that both lead and manganese levels are critical environmental factors potentially influencing MASLD development. The evidence underscores the need for further research into the mechanisms by which these metals affect liver health and the importance of public health initiatives aimed at reducing environmental exposure.

Implications for Public Health and Environmental Safety

The implications of this study’s findings extend beyond the individual to encompass broader public health and environmental safety concerns. High levels of lead and manganese in the environment are often linked to industrial activity, urbanization, and inadequate regulation of toxic substances. The results advocate for heightened awareness and stricter regulations regarding lead and manganese emissions, particularly in areas with vulnerable populations.

Recommendations for Public Health Policy

1. Monitoring and Regulation: Implement more stringent monitoring of lead and manganese levels in the environment, especially in urban areas.
2. Public Education: Develop educational programs to inform communities about the risks associated with lead and manganese exposure and ways to mitigate these risks.
3. Health Screening: Increase access to health screenings for populations at risk of elevated blood lead and manganese levels, particularly in industrial regions.

By addressing these environmental factors, public health initiatives can significantly impact the prevalence of MASLD and improve overall community health.

Future Research Directions on MASLD and Environmental Toxins

Future research should focus on elucidating the specific mechanisms through which lead and manganese contribute to MASLD. Longitudinal studies could provide insights into the temporal relationship between metal exposure and liver disease progression. Additionally, exploring genetic and epigenetic factors that may predispose individuals to the harmful effects of these metals could enhance understanding and inform targeted interventions.

Another key area for future investigation is the role of dietary factors and lifestyle choices in modulating the effects of lead and manganese on liver health. Understanding these interactions could lead to more comprehensive prevention strategies.

FAQ

What is MASLD?

MASLD stands for Metabolic Dysfunction-Associated Steatotic Liver Disease, a condition characterized by fat accumulation in the liver associated with metabolic risk factors.

How are blood lead and manganese related to MASLD?

Increased levels of blood lead and manganese have been correlated with higher rates of MASLD, suggesting that these metals may disrupt metabolic processes related to liver health.

How was the study conducted?

The study utilized data from the NHANES database, analyzing 4,475 participants to assess the relationship between blood lead and manganese levels and MASLD prevalence.

What are the public health implications?

The findings highlight the need for stricter regulations on lead and manganese emissions and increased public awareness regarding the risks of environmental exposure to these metals.

What are the future research directions?

Future research should investigate the mechanisms linking lead and manganese to MASLD, as well as dietary and lifestyle factors that may influence these effects.

References

1. Guo, W., Weng, T., & Song, Y. (2025). Impact of blood lead and manganese levels on metabolic dysfunction-associated steatotic liver disease prevalence: insights from NHANES (2017–2020). BMC Gastroenterology. https://doi.org/10.1186/s12876-025-03731-3

2. Yang, X., Liu, H., & Wu, X. (2025). High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management. Clin Exp Med. https://doi.org/10.1007/s10238-025-01577-3

3. Lacomba-Arnau, E., Martínez-Molina, A., & Barrós-Loscertales, A. (2025). Structural Cerebellar and Lateral Frontoparietal Networks are altered in CUD: An SBM Analysis. Addict Biol. https://pubmed.ncbi.nlm.nih.gov/11899759/

4. Extracellular vesicles lay the ground for neuronal plasticity by restoring mitochondrial function, cell metabolism and immune balance. PubMed

5. Jelodar, M. G., Malek-Ahmadi, M., Sahebnasagh, A., & Mohammadi, F. (2024). Efficacy and safety of medroxyprogesterone acetate on noninvasive ventilation -treated exacerbated COPD patients: a double-blind randomized clinical trial. BMC Pulm Med. https://doi.org/10.1186/s12890-024-03462-3